Stem Cell Conditioned Medium IV in Tokyo: Dental Pulp vs Umbilical Cord

Conditioned medium is a preparation obtained from the liquid used to culture cells, after cells and other material are removed. Its composition depends on its source and processing. “Stem cell supernatant” and “conditioned medium” may describe this category, but the name alone does not establish product equivalence.[1][2]

Ask for a written product description. A clinic offering living cells, a clinic using culture supernatant and a clinic advertising exosomes may be discussing different interventions. A comparison is useful only when it identifies what is actually administered and by which route.

Research directly comparing dental-pulp-derived and umbilical-cord-derived preparations has analysed differences in metabolites and secreted factors in conditioned medium. It was not a trial establishing which IV infusion is more effective or safer in people.[5]

These laboratory studies do not justify assigning “dental pulp for nerves” and “umbilical cord for the whole body” as fixed clinical uses, or declaring one universally superior. Ask what evidence relates to your concern, and which preparation and route would actually be used.

• The same source label does not establish the same composition, concentration or quality tests.
• mL measures liquid volume; it does not itself measure concentration, ingredient content or strength of effect.
• Discuss your symptoms, purpose, medical conditions, medicines and other treatment options with the clinician.

A July 2024 MHLW notice stated that, at that time, no medicines using these materials had demonstrated efficacy and safety and obtained marketing approval, including overseas. It called attention to safety and quality management. The notice is not approval of a clinic’s treatment.[1]

When reviewing a study, ask whether it concerns people with a comparable problem, the same preparation and the same route. Laboratory findings or local injections do not automatically establish a benefit from an IV infusion. A change in a blood marker is also different from an improvement that matters in everyday life.

• What was measured, and over what period?
• Was there a comparison group?
• How similar is the study preparation to the proposed product?
• What benefits, uncertainties and alternatives should influence the decision?

When comparing costs, identify whether the preparation is dental-pulp-derived or cord-derived, the amount per session, and whether consultation and tests are included. The same headline infusion price can lead to a different total when assessment fees or additional arrangements differ.

SWIFT’s fees will be provided after confirmation. This page does not establish a treatment price, total or course size. Check whether conditions differ for residents of Japan and visitors, the cost of any language assistance, and what consultation or test fees remain payable if an infusion does not proceed.

Before arranging travel around treatment, confirm when suitability will be assessed, which records are needed and how explanations and consent will be handled. An English webpage or booking screen does not establish that every part of medical care is available in English.

At a visit, review the product, proposed procedure, risks, alternatives and written quotation before deciding. If treatment proceeds, ask about follow-up, records to take home and a contact plan. These are planning questions, not a promise of a one-visit treatment, same-day infusion, interpreter service or remote aftercare.

Compare how clearly uncertainty is explained, not how many benefits are listed. Ask for information that you can review in your own language and discuss with your usual clinician if needed. You do not need to make a treatment decision before the relevant product and care arrangements are understood.